Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Glenmark Pharm Glenmark Pharma Ltd. | BSE 2006.90 -3.05 (-0.15%) | NSE 2009.70 -0.90 (-0.04%) | Trade | Add

BSE Live

Dec 29, 16:01

2006.90 -3.05 (-0.15%)

Volume

AVERAGE VOLUME

5-Day

24,513

10-Day

16,824

30-Day

22,672

5,497

Prev. Close

2009.95
Open Price

2043.00

Bid Price (Qty.)
2000.00 (6)
Offer Price (Qty.)
2028.20 (5)

NSE Live

Dec 29, 15:44

2009.70 -0.90 (-0.04%)

Volume

AVERAGE VOLUME

5-Day

632,515

10-Day

512,992

30-Day

928,187

266,984

Prev. Close

2010.60
Open Price

2012.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2009.70 (452)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Glenmark Pharma (in Rs. Cr.)	Mar 10	Mar 09	Mar 08	Mar 07	Mar 06
Per Share Ratios
Basic EPS (Rs.)	4.76	8.70	15.64	11.23	5.67
Diluted EPS (Rs.)	4.76	8.70	15.64	11.23	5.67
Cash EPS (Rs.)	5.55	9.46	16.82	13.18	7.14
Book Value [ExclRevalReserve]/Share (Rs.)	65.72	49.10	41.34	37.50	25.16
Book Value [InclRevalReserve]/Share (Rs.)	65.72	49.10	41.34	37.50	25.16
Dividend / Share(Rs.)	0.40	0.40	0.70	0.80	0.70
Revenue from Operations/Share (Rs.)	38.15	34.53	55.48	67.45	47.62
PBDIT/Share (Rs.)	8.97	14.38	20.27	19.46	10.13
PBIT/Share (Rs.)	8.18	13.62	19.09	17.51	8.65
PBT/Share (Rs.)	4.48	9.83	17.34	14.23	7.18
Net Profit/Share (Rs.)	4.76	8.70	15.64	11.23	5.67
Profitability Ratios
PBDIT Margin (%)	23.50	41.64	36.54	28.85	21.26
PBIT Margin (%)	21.43	39.43	34.41	25.95	18.17
PBT Margin (%)	11.75	28.47	31.24	21.09	15.08
Net Profit Margin (%)	12.47	25.19	28.19	16.64	11.90
Return on Networth / Equity (%)	7.24	17.71	37.83	29.94	22.52
Return on Capital Employed (%)	5.30	14.47	28.33	13.69	7.57
Return on Assets (%)	4.63	8.45	20.10	8.29	5.57
Total Debt/Equity (X)	0.43	0.86	0.51	2.02	2.44
Asset Turnover Ratio (%)	37.11	33.58	71.29	49.82	46.80
Liquidity Ratios
Current Ratio (X)	4.38	1.98	2.02	1.64	2.66
Quick Ratio (X)	3.95	1.86	1.53	1.30	2.23
Inventory Turnover Ratio (X)	6.85	6.64	5.04	3.71	4.07
Dividend Payout Ratio (NP) (%)	8.40	4.59	4.40	7.10	12.34
Dividend Payout Ratio (CP) (%)	7.20	4.22	4.09	6.05	9.80
Earnings Retention Ratio (%)	91.60	95.41	95.60	92.90	87.66
Cash Earnings Retention Ratio (%)	92.80	95.78	95.91	93.95	90.20
Valuation Ratios
Enterprise Value (Cr.)	7,933.77	5,002.87	12,718.35	8,217.23	4,389.69
EV/Net Operating Revenue (X)	7.71	5.78	9.22	10.15	7.76
EV/EBITDA (X)	32.79	13.89	25.22	35.17	36.51
MarketCap/Net Operating Revenue (X)	6.98	4.57	8.85	9.04	6.60
Retention Ratios (%)	91.59	95.40	95.59	92.89	87.65
Price/BV (X)	4.05	3.21	11.87	16.26	12.49
Price/Net Operating Revenue	6.98	4.57	8.85	9.04	6.60
Earnings Yield	0.02	0.06	0.03	0.02	0.02